Current Antibiotic Treatment for Chlamydia
The current first-line treatment for uncomplicated chlamydial infection is either azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days, both with approximately 97-98% efficacy rates. 1, 2
First-Line Treatment Options
Azithromycin 1 g orally as a single dose is the preferred option when compliance is questionable, as it allows for directly observed therapy and eliminates concerns about adherence to multi-day regimens 1, 2
Doxycycline 100 mg orally twice daily for 7 days is equally efficacious to azithromycin with a 98% cure rate, costs less, and has more extensive clinical experience over a longer period 1, 2
Meta-analyses of randomized controlled trials demonstrate that azithromycin and doxycycline are equally effective for genital chlamydial infections, with similar rates of mild-to-moderate side effects 2, 3
Alternative Treatment Regimens
When first-line options cannot be used, the following alternatives are recommended 4, 1:
- Erythromycin base 500 mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
- Ofloxacin 300 mg orally twice daily for 7 days
- Levofloxacin 500 mg orally once daily for 7 days
Important caveat: Erythromycin is less efficacious than azithromycin or doxycycline, and gastrointestinal side effects frequently lead to poor compliance, making it a less desirable alternative 4, 2
Special Population Considerations
Pregnancy
- Azithromycin 1 g orally as a single dose is the preferred treatment during pregnancy 1
- Amoxicillin 500 mg orally three times daily for 7 days is an acceptable alternative 1, 2
- Doxycycline and ofloxacin are absolutely contraindicated during pregnancy 1, 5
- Pregnant women should always undergo test-of-cure 3-4 weeks after treatment completion due to use of alternative regimens with lower efficacy 1
Pediatric Dosing
- For children ≥8 years weighing >45 kg: azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days 1
- For children <45 kg: erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into four doses daily for 14 days 1
Implementation Best Practices
Medications should be dispensed on-site when possible, with the first dose directly observed to maximize compliance 1, 2
Patients must abstain from all sexual intercourse for 7 days after initiating treatment and until all sex partners have been treated to prevent reinfection 1, 2
Doxycycline should be administered with adequate fluids to reduce risk of esophageal irritation and ulceration 5
If gastric irritation occurs with doxycycline, it should be given with food or milk, as absorption is not markedly influenced by simultaneous ingestion 5
Partner Management
All sex partners from the previous 60 days must be evaluated, tested, and empirically treated 1, 2
If the last sexual contact was >60 days before diagnosis, the most recent partner should still be treated 1, 2
Failing to treat sex partners leads to reinfection in up to 20% of cases 1
Follow-Up Recommendations
Test-of-cure is NOT recommended for non-pregnant patients treated with azithromycin or doxycycline unless therapeutic compliance is questionable, symptoms persist, or reinfection is suspected 1, 2
Testing before 3 weeks post-treatment is unreliable because nucleic acid amplification tests can yield false-positive results from dead organisms that persist after successful treatment 1
All women with chlamydia should be retested approximately 3 months after treatment to screen for reinfection, regardless of whether partners were reportedly treated 1, 2
Repeat infections carry an elevated risk for pelvic inflammatory disease and other complications compared to initial infection 4, 1
Additional Testing at Initial Visit
Patients diagnosed with chlamydia should be tested for gonorrhea, syphilis, and HIV at the initial visit 1
Coinfection with gonorrhea is common, and presumptive treatment for chlamydia should be provided when gonorrhea is confirmed 4, 1
Common Pitfalls to Avoid
Do not use erythromycin as first-line treatment due to poor compliance from gastrointestinal side effects and lower efficacy 4, 2
Do not perform test-of-cure before 3 weeks post-treatment, as this leads to false-positive results 1
Do not prescribe doxycycline during pregnancy—it is absolutely contraindicated 1, 5
Do not neglect partner treatment, as this significantly increases reinfection risk and perpetuates transmission 1